OK Biotech Co Ltd
TWSE:4155

Watchlist Manager
OK Biotech Co Ltd Logo
OK Biotech Co Ltd
TWSE:4155
Watchlist
Price: 19.85 TWD 0.51% Market Closed
Market Cap: 2.9B TWD
Have any thoughts about
OK Biotech Co Ltd?
Write Note
OK Biotech Co Ltd
/
Income Statement
/
Cost of Revenue

OK Biotech Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

OK Biotech Co Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
OK Biotech Co Ltd
TWSE:4155
Cost of Revenue
-NT$1.1B
CAGR 3-Years
-1%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
M
Medtecs International Corporation Ltd
SGX:546
Cost of Revenue
-$46.8m
CAGR 3-Years
35%
CAGR 5-Years
4%
CAGR 10-Years
-1%
V
Visco Vision Inc
TWSE:6782
Cost of Revenue
-NT$1.5B
CAGR 3-Years
-16%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
P
Pegavision Corp
TWSE:6491
Cost of Revenue
-NT$3.1B
CAGR 3-Years
-9%
CAGR 5-Years
-47%
CAGR 10-Years
N/A
SciVision Biotech Inc
TWSE:1786
Cost of Revenue
-NT$209.7m
CAGR 3-Years
-12%
CAGR 5-Years
-9%
CAGR 10-Years
-10%
No Stocks Found

OK Biotech Co Ltd
Glance View

Market Cap
2.9B TWD
Industry
Health Care

OK Biotech Co. Ltd. engages in the manufacture, wholesale, trade, and retail of medical equipment and related homecare medical products. The company is headquartered in Hsinchu, Hsinchu. The company went IPO on 2010-12-30. The firm primarily provides household medical glucose meters and disposable glucose testing strips. Its products are applied in the testing and monitoring of glucose value for diabetes patients, hospitals, clinic doctors and nurses, among others. The firm distributes its products principally in Taiwan, other Asian markets and the United States.

Intrinsic Value
13.65 TWD
Overvaluation 31%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is OK Biotech Co Ltd's Cost of Revenue?
Cost of Revenue
-1.1B TWD

Based on the financial report for Jun 30, 2024, OK Biotech Co Ltd's Cost of Revenue amounts to -1.1B TWD.

What is OK Biotech Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-7%

Over the last year, the Cost of Revenue growth was -16%. The average annual Cost of Revenue growth rates for OK Biotech Co Ltd have been -1% over the past three years , -7% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 215,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.